Tokio Marine Asset Management CO LTD Eli Lilly & CO Transaction History

Tokio Marine Asset Management CO LTD

$1.96 Billion
Q1 2024

A detailed history of Tokio Marine Asset Management CO LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 44,308 shares of LLY stock, worth $40.1 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares

44,308

Previous 47,809 7.32%

Holding current value

$40.1 Million

Previous $27.9 Million 23.69%

% of portfolio

1.76%

Previous 1.54%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $2.07 Million - $2.77 Million	-3,501 Reduced 7.32%	44,308 $34.5 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $298,307 - $351,665	568 Added 1.2%	47,809 $27.9 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $325,590 - $448,875	-749 Reduced 1.56%	47,241 $25.4 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $724,628 - $968,912	2,066 Added 4.5%	47,990 $22.5 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $10.1 Million - $11.9 Million	32,502 Added 242.15%	45,924 $15.8 Million

Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $441,488 - $514,421	1,373 Added 11.4%	13,422 $0
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $378,604 - $431,459	1,277 Added 11.85%	12,049 $3.9 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $511,748 - $600,867	1,836 Added 20.55%	10,772 $3.49 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $259,801 - $322,867	-1,107 Reduced 11.02%	8,936 $2.56 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $51,490 - $63,900	229 Added 2.33%	10,043 $2.77 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $107,032 - $131,718	483 Added 5.18%	9,814 $2.27 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $27,804 - $35,965	-154 Reduced 1.62%	9,331 $2.14 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $660,895 - $855,559	4,022 Added 73.62%	9,485 $1.77 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $55,315 - $73,195	424 Added 8.41%	5,463 $922,000
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $85,246 - $98,602	583 Added 13.08%	5,039 $746,000
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $78,714 - $94,731	577 Added 14.87%	4,456 $732,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $82,263 - $101,818	-691 Reduced 15.12%	3,879 $538,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $30,472 - $37,742	285 Added 6.65%	4,570 $601,000
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $24,882 - $27,065	233 Added 5.75%	4,285 $479,000
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $56,170 - $65,565	507 Added 14.3%	4,052 $449,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $188,336 - $221,685	-1,692 Reduced 32.31%	3,545 $460,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $22,027 - $24,677	-208 Reduced 3.82%	5,237 $606,000
Q3 2018 Oct 23, 2018	SELL	$85.86 - $107.31 $105,178 - $131,454	-1,225 Reduced 18.37%	5,445 $584,000
Q2 2018 Jul 18, 2018	SELL	$75.7 - $86.88 $706,962 - $811,372	-9,339 Reduced 58.34%	6,670 $569,000
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $3.81 Million - $4.5 Million	-51,377 Reduced 76.24%	16,009 $1.24 Million
Q4 2017 Feb 05, 2018	SELL	$81.94 - $87.89 $155,604 - $166,903	-1,899 Reduced 2.74%	67,386 $5.69 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $434,135 - $481,846	5,633 Added 8.85%	69,285 $5.93 Million
Q2 2017 Jan 11, 2018	BUY	N/A	7,051 Added 12.46%	63,652 $5.24 Million
Q1 2017 Jan 11, 2018	SELL	N/A	-17,167 Reduced 23.27%	56,601 $4.76 Million
Q4 2016 Jan 11, 2018	SELL	N/A	-11,667 Reduced 13.66%	73,768 $5.43 Million
Q3 2016 Jan 11, 2018	SELL	N/A	-6,260 Reduced 6.83%	85,435 $6.86 Million
Q2 2016 Jan 11, 2018	BUY	N/A	829 Added 0.91%	91,695 $7.22 Million
Q1 2016 Jan 11, 2018	BUY	N/A	90,866	90,866 $6.54 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.

Account

Tokio Marine Asset Management CO LTD Eli Lilly & CO Transaction History